Anti-GD2 ADC M3554 in Advanced Solid Tumors

Clinical trial NCT06641908 · RECRUITING

Trial details

NCT number: NCT06641908
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-11-08
Primary completion: 2027-04-16
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.